Webinars & Industry Presentations
Other Areas of Experience and Expertise
| Nephrology |
Transplant Rejection |
- Assessment of novel metallomatrix pathway-targeting agent for diabetic neuropathy
- Evaluation and forecasting of drug delivery play on erythropoietin
- Assessment of novel MOA for ESRD
- Opportunity search for development products within the renal space
|
- Evaluation and forecasting of next generation calcineurin inhibitors with improved tolerability proposition
- Evaluation of novel, tolerizing biologicals for transplant and other immune settings
- Evaluation of targeted anti-lymphocyte cell surface-targeting monoclonal for SCT and SOT
|
| Urology |
Women’s Health |
- Scientific and commercial assessment of a novel biologic therapy for superficial bladder cancer
- Development of an in-licensing/acquisition strategy for a nascent urology franchise
- Critical evaluation of clinical development and market positioning strategies for a first-in-class therapy (benign prostatic hyperplasia and hypogonadism)
|
- Assessment of future market for female sexual dysfunction, including forecast for several pipeline agents
- Evaluation of novel MOA for the treatment of vasomotor symptoms
- Detailed evaluation of urinary incontinence/overactive bladder market and revenue potential for a niche market opportunity
|
| Ophthalmology |
Dermatology |
- Assessment, partner identification, and sales force estimates for cell based therapy for corneal surface disorders
- Evaluation and forecast of next generation anti-VEGF therapies for wet AMD (several projects)
- Market landscape and pipeline evaluations for major ophthalmology segments of glaucoma, retinal disease, and dry eye
|
- Evaluation & forecast of next generation cosmetic fillers and botulinum toxin products
- Evaluation & forecast for topical products aimed at treating actinic keratoses and cutaneous warts
- Search projects aimed at identifying potential “corner property” acquisitions for dermatology including evaluation of typical products for acne, psoriasis, and other common dermatology indications
|
| Orphan’s Diseases |
Gastroenterology |
- Market assessments for expanded indications of marketed injectable product for spasticity, and other orphan indications
- Detailed competitive analysis & recommendations for next generation approaches in blood diseases such as hemophilia, ITP, & myelodysplastic syndromes
- Opportunity searches for potential in-licensing and acquisition targets for orphan metabolic diseases, cystic fibrosis, and pulmonary hypertension
|
- Evaluation and forecasting of products for post-operative ileus, inflammatory bowel disease (biologicals/small molecules), and ‘topical’ steroids
- Analysis of the pancreatic enzyme market and recommendation of a competitive positioning
- Assisted a biotechnology company with identification and prioritization of potential in-licensing opportunities focused on indications in the GI specialty setting
|
